Pneumocystis jirovecii Pneumonia in HIV-Negative, Non-transplant Patients: Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention-Reference-Cited by-同舟云学术

Pneumocystis jirovecii Pneumonia in HIV-Negative, Non-transplant Patients: Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention

Published:2024-01-20 Issue:2 Volume:18 Page:125-135
ISSN:1936-3761
Container-title:Current Fungal Infection Reports
language:en
Short-container-title:Curr Fungal Infect Rep

Author:

Rhoads Sarah,Maloney James,Mantha Aditya,Van Hook Reed,Henao-Martínez Andrés F.

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12281-024-00482-8.pdf

Reference73 articles.

1. Sokulska M, Kicia M, Wesołowska M, Hendrich AB. Pneumocystis jirovecii–from a commensal to pathogen: clinical and diagnostic review. Parasitol Res. 2015;114(10):3577–85. https://doi.org/10.1007/s00436-015-4678-6.

2. Xue T, Kong X, Ma L. Trends in the epidemiology of Pneumocystis pneumonia inn immunocompromised patients without HIV infection. J Fungi (Basel). 2023;9(8):812. https://doi.org/10.3390/jof9080812.

3. Pereira-Díaz E, Moreno-Verdejo F, de la Horra C, Guerrero JA, Calderón EJ, Medrano FJ. Changing trends in the epidemiology and risk factors of Pneumocystis pneumonia in Spain. Front Public Health. 2019;4(7):275. https://doi.org/10.3389/fpubh.2019.00275.

4. Pates K, Periselneris J, Russell MD, Mehra V, Schelenz S, Galloway JB. Rising incidence of Pneumocystis pneumonia: a population-level descriptive ecological study in England. J Infect. 2023;86(4):385–90. https://doi.org/10.1016/j.jinf.2023.02.014.

5. Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis. 2019;68:1791–7.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cotrimoxazole/prednisone;Reactions Weekly;2024-07-27